Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:42 AM
Ignite Modification Date:
2025-12-25 @ 1:42 AM
NCT ID:
NCT04807894
Eligibility Criteria:
Inclusion Criteria:
* 60-90 yo Female
* Postmenopausal
* Recurrent UTIs (three or more culture confirmed symptomatic episodes of UTI or two or more in the past 6 months).
* English Proficiency
* Unable or unwilling to use topical estrogen.
* Patients with history of or current endometrial or breast cancer and current aromatase inhibitor therapy may also be included in study.
* Patient on oral estrogen therapy may be included.
* Patient with slings, prior vaginal surgery or pessary may be included.
Exclusion Criteria:
* Current UTI/ Dipstick and culture positive (\> trace leukocytes or nitrites)
* Antibiotic (vaginal or oral) use in the last 4 weeks
* Current sexually transmitted infection
* Chronic Foley catheter use or chronic ureteral stent placement.
* Vaginal probiotic use in the last 4 weeks
* Patient currently using vaginal estrogen.
* Post-void Residual Volume \>150 mL or current diagnosis of urinary retention
* Non-evaluated hematuria (\> trace on dipstick, microscopic, gross)
* Unable to complete study tasks or comply with follow up.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
60 Years
Maximum Age:
90 Years
Study:
NCT04807894
Study Brief:
Protocol Section:
NCT04807894